FDA, EMA accept Pfizer’s BLP application for hemophilia therapy
HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.
Drugs
Medical
Pharma
Drugs
Health
Pharma
Pfizer gets FDA nod for combination drug to treat advanced prostate cancer
HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.
Drugs
Medical
Pharma
France’s Valneva says trial vaccine for chikungunya post 98.9% rate
HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.